A Phase 3 Open Label Multicenter Study of I124 Evuzamitide as an Imaging Agent for the Diagnosis of Cardiac Amyloidosis Using Positron Emission Tomography Computed Tomography PETCT
Year: 2026
Type: article
Source: Journal of Nuclear Cardiology
Authors: Sharmila Dorbala, Mathew S. Maurer, Sarah AM. Cuddy, Michel G. Khouri, Joshua D. Mitchell, Brett W. Sperry, Mazen Hanna, Omar Abou Ezzeddine, Saurabh Malhotra, Jonathan S. Wall, Spencer Guthrie, Brian Mangal, Marcelo F. Di Carli, Frederick L. Ruberg, Vasken Dilsizian, Angela Dispenzieri, James E. Udelson, Ravi K. Narra, Ahmad Masri
Institutions: Brigham and Women's Hospital, Columbia University, Duke University Health System, Washington University in St. Louis, Saint Luke's Hospital, Cleveland Clinic, Mayo Clinic, Cook County Health and Hospitals System, University of Tennessee at Knoxville, Bayer (Germany), Boston University, University of Maryland, Baltimore, Tufts Medical Center, Medical College of Wisconsin, Oregon Health & Science University
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7212021731